Angiotensin Ii Acetate Patent Expiration
Angiotensin Ii Acetate is used for increasing blood pressure and treating shock, especially in patients unresponsive to other vasopressors. It was first introduced by La Jolla Pharma Llc
Angiotensin Ii Acetate Patents
Given below is the list of patents protecting Angiotensin Ii Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Giapreza | US11219662 | Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II | Jan 06, 2037 | La Jolla Pharma |
| Giapreza | US10028995 | Angiotensin II alone or in combination for the treatment of hypotension | Dec 18, 2034 | La Jolla Pharma |
| Giapreza | US10493124 | Angiotensin II alone or in combination for the treatment of hypotension | Dec 18, 2034 | La Jolla Pharma |
| Giapreza | US11096983 | Angiotensin II alone or in combination for the treatment of hypotension | Dec 18, 2034 | La Jolla Pharma |
| Giapreza | US11559559 | Angiotensin II alone or in combination for the treatment of hypotension | Dec 18, 2034 | La Jolla Pharma |
| Giapreza | US9220745 | Angiotensin II alone or in combination for the treatment of hypotension | Dec 18, 2034 | La Jolla Pharma |
| Giapreza | US9572856 | Method of treating low blood pressure | Jul 18, 2031 | La Jolla Pharma |
| Giapreza | US9572856 | Method of treating low blood pressure | Nov 20, 2030 | La Jolla Pharma |
| Giapreza | US10335451 | Method of treating low blood pressure | Dec 16, 2029 | La Jolla Pharma |
| Giapreza | US10500247 | Method of treating low blood pressure | Dec 16, 2029 | La Jolla Pharma |
| Giapreza | US10548943 | Method of treating low blood pressure | Dec 16, 2029 | La Jolla Pharma |
| Giapreza | US9867863 | Method of treating low blood pressure | Dec 16, 2029 | La Jolla Pharma |
Angiotensin Ii Acetate's Family Patents
Explore Our Curated Drug Screens
Angiotensin Ii Acetate Generic API Manufacturers
Only one generic application has been filed for Angiotensin Ii Acetate.
Given below is the list of companies who have filed for Angiotensin Ii Acetate generic, along with the locations of their manufacturing plants worldwide.
1. GLAND
Gland Pharma Ltd has filed for 1 generic for Angiotensin Ii Acetate. This eq 2.5mg base/ml (eq 2.5mg base/ml) version comes by the name ANGIOTENSIN ll ACETATE. Given below are the details of the strengths of this generic introduced by Gland.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 3, 2025 |
Manufacturing Plant Locations New
Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||